Host Cell Glycosylation of Viral Glycoproteins - a Battlefield for Host Defence and Viral Resistance

References

• Deryckere F, Burgert HG. Early region 3 (E3) of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C. J Virol 1996; 70: 2832–41.
   PubMed Web of Science ®Google Scholar
• Tiggs MA, Leng S, Johnson DC, Burke RL. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J Immunol 1996; 156: 3901–10.
   PubMed Web of Science ®Google Scholar
• Datema R, Olofsson S, Romero P. Inhibitors of protein glycosylation and glycoprotein processing in viral systems. Pharmac Ther 1987; 33: 221–86.
   Google Scholar
• Roseman S. Complex carbohydrates and intercellular adhesion. In: Lee EYC, Smith EE, eds. Biology and chemistry of eucaryotic cell surfaces. New York: Academic Press 1974: 317–54.
   Google Scholar
• Losick R, Robbins PW. Mechanism of epsilon-15 conversion studied with a bacterial mutant. J Mol Biol 1967; 30: 445–55.
   PubMed Web of Science ®Google Scholar
• O′Reilly DR, Miller RK. A baculovirus blocks insect molting by producing ecdysteroid UDP-glucosyl transferase. Science 1989; 245: 1110–2.
   PubMed Web of Science ®Google Scholar
• Kozutsumi Y, Segal M, Normington K, Gething MJ, Sam-brook J. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 1988; 332: 462–4.
   Google Scholar
• Hurtley SM, Bole DG, Hoover-Litty H, Helenius A, Copeland CS. Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP). J Cell Biol 1989; 108: 2117–26.
   Google Scholar
• Hansen JE. Carbohydrates of human immunodeficiency virus. APMIS 1992; Suppl 27: 96–108.
   Google Scholar
• Olofsson S. Carbohydrates in herpesvirus infections. APMIS 1992; 100: 84–95.
   Web of Science ®Google Scholar
• Skehel JJ, Stevens DJ, Daniels RS, Douglas HR, Knossow M, Wilson IA, Wiley DC. A carbohydrate side chain on hemagglutinin of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci USA 1984; 81: 1779–83.
   Google Scholar
• Munk K, Pritzer E, Kretzschmar E, Gutte B, Garten W, Klenk HD. Carbohydrate masking of an antigenic epitope of influenza virus haemagglutinin independent of oligosaccharide size. Glycobiology 1992; 2: 233–40.
   PubMed Web of Science ®Google Scholar
• Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990; 265: 10373–82.
   PubMed Web of Science ®Google Scholar
• Geyer H, Holschbach C, Hunsmann G. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein gp120. J Biol Chem 1988; 263: 11760–7.
   Google Scholar
• Levy JA. Pathogenesis of human immunideficiency virus. Microbiolog Rev 1993; 57: 183–289.
   PubMedGoogle Scholar
• Schønning K, Jansson B, Olofsson S, Hansen J-ES. Rapid selection of an N-linked oligosaccharide by monoclonal antibodies against the V3-loop of HIV-1. J Gen Virol 1996; 77: 753–8.
   Google Scholar
• Schønning K, Jansson B, Olofsson S, Nielsen JO, Hansen J-ES. Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quartenary structure of the HIV-1 envelope oligomer. Virology 1996; 218: 134–40.
   Google Scholar
• Arendrup M, Sönnerborg A, Åkerblom L, Nielsen C, Clausen H, Nielsen JO, Olofsson S, Hansen J-ES. Neutralization antibody response during HIV-1 infection: type-and group-specificity and viral escape. J Gen Virol 1993; 74: 855–63.
   PubMed Web of Science ®Google Scholar
• Myers G, Korber B, Berzofsky JA, Smith RF, Pavlakis GN. Los Alamos. Los Alamos National Laboratory, 1992.
   Google Scholar
• Clausen H, Bennett EP, Dabelsteen E. Carbohydrates of the cell surface: molecular aspects of glycosyl transferases and their genes. APMIS 1992; 100: 9–17.
   Google Scholar
• Adachi M, Hayami M, Kashiwagi N, Mizuta T, Ohta Gill MJ, Matheson DS, Tamaoki T, Shiozawa C, Hakomori S-I. Expression of Ley antigen in human immunodeficiency virus-infected human T-cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex. J Exp Med 1988; 167: 323–31.
   Google Scholar
• Hansen JE, Clausen H, Nielsen C, Teglbjaerg LS, Hansen LL, Nielsen CM, Dabelsteen E, Mathiesen L, Hakomori SI, Nielsen JO. Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization. J Virol 1990; 64: 2833–40.
   PubMed Web of Science ®Google Scholar
• Hansen J-ES, Nielsen C, Arendrup M, Olofsson S, Mathiesen LR, Nielsen JO, Clausen H. Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus. J Virol 1991; 65: 6461–7.
   Google Scholar
• Miyoshi E, Nishikawa A, Ihara Y, Hayashi N, Fusamoto H, Kamada T, Taniguchi N. Selective suppression of N-acetylglucosaminyltransferase III activity in a human hepatoblastoma cell line transfected with hepatitis B virus. Cancer Res 1994; 54: 1854–8.
   Google Scholar
• Löwer J, Davidson E, Teich NM, Weiss RA, Joseph AP, Kurth R. Heterophil antibodies recognize oncovirus envelope antigens: epidemiological parameters and immunological specificity of the reaction. Virology 1981; 109: 409–17.
   Google Scholar
• Klenk H-D. Influence of glycosylation on antigenicity of viral proteins. In: van Regenmortel MHV, Neurath AR, eds. The basis for serodiagnosis and vaccins. Amsterdam: Elsevier, 1990: 25–37.
   Google Scholar
• Boccardi V, Attina D, Girelli G. Influnece of orally administered antibiotocs on anti-T agglutinin of normal subjects and of cirrhotic patients. Vox sanguinis 1974; 27: 268–72.
   Google Scholar
• Takeuchi Y, Porter CD, Strahan KM, Preece AF, Gustafsson K, Cosset FL, Weiss RA, Collins MK. Sensitization of cells and retroviruses to human serum by (alpha 1–3) galactosyltransferase. Nature 1996; 379: 85–8.
   PubMed Web of Science ®Google Scholar
• Galili U, Swanson K. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA 1991; 88: 7401–4.
   PubMed Web of Science ®Google Scholar
• Welsh RMJ, Cooper NR, Jensen FC, Oldstone MB. Human serum lyses RNA tumour viruses. Nature 1975; 257: 612–4.
   PubMed Web of Science ®Google Scholar
• Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730–7.
   Google Scholar
• Repik PM, Strizki JM, Galili U. Differential host dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model. J Gen Virol 1994; 75: 1177–81.
   Google Scholar
• Bach FH, Robson SC, Winkler H, Ferran C, Stuhlmeier KM, Wrighton CJ, Hancock WW. Barriers to xenotransplantation. Nature Med 1995; 1: 869–73.
   Google Scholar
• Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3: 282–6.
   Google Scholar
• Weiss R. Transgenic pigs and virus adaption. Nature 1998; 391: 327–8.
   PubMed Web of Science ®Google Scholar
• Matthews TJ, Langlois A, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci USA 1986; 83: 513–8.
   Google Scholar
• Rother RP, Fodor WL, Springhorn JP, Birks CW, Setter E, Sandrin MS, Squinto SP, Rollins SA. A novel mechanism of retrovirus inactivation in human serum mediated by antigalactosyl natural antibody. J Exp Med 1995; 182: 1345–55.
   PubMed Web of Science ®Google Scholar
• Olofsson S, Jeansson S, Hansen J-ES. Use of lectins in general and diagnostic virology. In: Doyle, RJ, Slifkin, M, eds. Lectin-microrganism interactions. New York: Marcel Dekker Inc, 1994:67–109.
   Google Scholar
• Arendup M, Hansen JE, Clausen H, Nielsen C, Mathiesen LR, Nielson JO. Antibody to histo-blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from blood group B or O donors. AIDS 1991; 5: 441–4.
   PubMed Web of Science ®Google Scholar